Axim Biotechnologies Stock Current Liabilities
| AXIM Stock | USD 0.01 0.0003 2.91% |
Axim Biotechnologies fundamentals help investors to digest information that contributes to Axim Biotechnologies' financial success or failures. It also enables traders to predict the movement of Axim OTC Stock. The fundamental analysis module provides a way to measure Axim Biotechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axim Biotechnologies otc stock.
Axim |
Axim Biotechnologies OTC Stock Current Liabilities Analysis
Axim Biotechnologies' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Axim Biotechnologies Current Liabilities | 2.55 M |
Most of Axim Biotechnologies' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axim Biotechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Axim Biotechnologies has a Current Liabilities of 2.55 M. This is 99.85% lower than that of the Biotechnology sector and 99.53% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.97% higher than that of the company.
Axim Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axim Biotechnologies' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Axim Biotechnologies could also be used in its relative valuation, which is a method of valuing Axim Biotechnologies by comparing valuation metrics of similar companies.Axim Biotechnologies is currently under evaluation in current liabilities category among related companies.
Axim Fundamentals
| Return On Equity | -100.19 | |||
| Return On Asset | -0.35 | |||
| Operating Margin | (847.86) % | |||
| Current Valuation | 13.6 M | |||
| Shares Outstanding | 186.44 M | |||
| Shares Owned By Insiders | 40.97 % | |||
| Price To Earning | (53.71) X | |||
| Price To Book | 2.86 X | |||
| Price To Sales | 943.93 X | |||
| Revenue | 60.46 K | |||
| Gross Profit | 60.46 K | |||
| EBITDA | (13.42 M) | |||
| Net Income | (16.03 M) | |||
| Cash And Equivalents | 65.16 K | |||
| Total Debt | 5.06 M | |||
| Debt To Equity | 1.36 % | |||
| Current Ratio | 0.06 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.49 M) | |||
| Earnings Per Share | (0.13) X | |||
| Beta | 1.49 | |||
| Market Capitalization | 4.64 M | |||
| Total Asset | 5.32 M | |||
| Retained Earnings | (36.37 M) | |||
| Working Capital | (1.36 M) | |||
| Current Asset | 1.18 M | |||
| Current Liabilities | 2.55 M | |||
| Z Score | -15.0 | |||
| Net Asset | 5.32 M |
About Axim Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axim Biotechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axim Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axim Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Axim Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axim Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axim Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Axim OTC Stock
| 0.89 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
| 0.86 | BAC | Bank of America Sell-off Trend | PairCorr |
| 0.85 | CAT | Caterpillar Earnings Call Today | PairCorr |
| 0.82 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.81 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Axim Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axim Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axim Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axim Biotechnologies to buy it.
The correlation of Axim Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axim Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axim Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axim Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axim Biotechnologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Axim OTC Stock analysis
When running Axim Biotechnologies' price analysis, check to measure Axim Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axim Biotechnologies is operating at the current time. Most of Axim Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Axim Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axim Biotechnologies' price. Additionally, you may evaluate how the addition of Axim Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |